Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 246
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05884801 | Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors | ||
| NCT06732323 | A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer | ||
| NCT07041788 | Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC | ||
| NCT06852456 | QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma | ||
| NCT07344051 | A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis | ||
| NCT07079228 | A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer | ||
| NCT06254235 | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers | ||
| NCT06949761 | A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation | ||
| NCT05398861 | Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer | ||
| NCT07416058 | PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC | ||
| NCT04641754 | A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer | ||
| NCT05446883 | QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | ||
| NCT03267654 | Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance | ||
| NCT07861139 | Comparative Study of QL1209 and Perjeta® in Healthy Male Participants | ||
| NCT06942767 | Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | ||
| NCT05528198 | Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers | ||
| NCT05823285 | A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients | ||
| NCT05648669 | A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain | ||
| NCT01946919 | Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study | ||
| NCT06500507 | A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma | ||
| NCT07511647 | A Phase 3 Clinical Study of QL2106 Injection | ||
| NCT04550949 | To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors | ||
| NCT06980909 | The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects | ||
| NCT07622836 | A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer. | ||
| NCT05345236 | A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD) | ||
| NCT05758519 | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 | ||
| NCT07061639 | A Study of QLS5133 Monotherapy in Advanced Solid Tumors | ||
| NCT07679711 | Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects | ||
| NCT07327697 | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects | ||
| NCT05262413 | A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC) | ||
| NCT06749899 | QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. | ||
| NCT07138885 | A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma | ||
| NCT04651036 | A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects | ||
| NCT03195569 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer | ||
| NCT07489612 | QLS1410 in Participants With Uncontrolled Hypertension | ||
| NCT07417917 | QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa | ||
| NCT05716126 | Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers | ||
| NCT06884891 | A Phase Ⅲ Comparative Study of QL2108 to Dupixent® | ||
| NCT04233151 | QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety | ||
| NCT07089186 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections | ||
| NCT06750341 | Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol | ||
| NCT03389815 | A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients | ||
| NCT03244085 | A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients | ||
| NCT07138833 | A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS) | ||
| NCT06823609 | Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors | ||
| NCT07302516 | Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma | ||
| NCT05621330 | Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia | ||
| NCT07487103 | Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes | ||
| NCT07131345 | Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma | ||
| NCT05690945 | A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer |
